Results 261 to 270 of about 767,750 (322)

Tumor‐Adhesive Chitosan‐Derived Multi‐Immune Agonist Unleashes Strong and Durable Anti‐Cancer Immunity

open access: yesAdvanced Science, EarlyView.
A tumor‐adhesive chitosan‐derived immune agonist TACTIC is developed for strong and durable anti‐tumor immunity. The immune agonist exhibits multi‐targets and modulates both tumor cell immunogenicity and pro‐inflammatory responses in immune cells, thereby potentiating the therapeutic efficacy of clinical radiotherapy.
Huilan He   +8 more
wiley   +1 more source

Outcomes of percutaneous transhepatic gallbladder drainage versus percutaneous transhepatic biliary drainage for obstructive jaundice. [PDF]

open access: yesPLoS One
Azami T   +9 more
europepmc   +1 more source

Wearable Standalone Sensing Systems for Smart Agriculture

open access: yesAdvanced Science, EarlyView.
This review explores the development and application of wearable sensing systems for plant health monitoring. It examines different types of wearable plant sensors, including their design, working principles, and material choices, with an emphasis on their suitability for real‐world agricultural applications.
Dongpil Kim   +5 more
wiley   +1 more source

Reshape the Fates of Treg and CD8+T Cells Through IL‐2Rα by Synergizing Divergent Receptor‐Biased IL‐2 PEGylates

open access: yesAdvanced Science, EarlyView.
This study presents receptor‐biased IL‐2 PEGylates that selectively modulate IL‐2 receptor subunit interactions to enhance CD8⁺ T cell antitumor activity while curbing Treg activation and endothelial toxicity. The combined not‐α and not‐β variants balance immune stimulation and prevent T cell exhaustion, offering a novel, fine‐tuned approach for ...
Jiaqi Sun   +23 more
wiley   +1 more source

Spontaneous obliteration of a greater sphenoid wing dural arteriovenous fistula involving the diploic venous system. [PDF]

open access: yesSurg Neurol Int
Iampreechakul P   +6 more
europepmc   +1 more source

A Methionine Allocation Nanoregulator for the Suppression of Cancer Stem Cells and Support to the Immune Cells by Epigenetic Regulation

open access: yesAdvanced Science, EarlyView.
A nanoregulator interfering with intratumoral methionine competition is designed to deliver oxaliplatin (IV) prodrugs and anti‐Lat4 small interfering RNA to tumor cells. This Pt (IV)‐crosslinked reduction‐sensitive nanoregulator progressively releases drugs within tumor cells and induces immunogenic cell death.
Boyu Su   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy